ACUITY STRATEGIC PARTNERS LLC

Biopharma

Latest filing May 18, 2026

Government Consulting

$150K

Reported income

Defense leads by disclosed activity

Filings

Most recent on May 18, 2026

Clients represented

NANODX leads by reported income

Lobbyists employed

MICHAEL J EGING appears most prominently

Reported Income Over Time

Annual totals based on disclosed filing amounts.

2025

$90K4 filings

2026

$60K4 filings

Client Portfolio

The clients this firm represents, ranked by disclosed filing amounts.

NANODX

Biopharma

5 filingsLatest May 18, 2026

Manufacturing Medical Devices, point-of-care diagnostic solutions

$150K

STUDENTS FOR LIFE OF AMERICA

Nonprofit & Advocacy

3 filingsLatest May 18, 2026

Clean water advocacy for american cities

What They Lobby On

Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.

Defense

DEF

5 mentions5 filingsLatest May 18, 2026

$60K

apportioned income

HOUSE OF REPRESENTATIVES5SENATE5

Medicare/Medicaid

MMM

Government Touchpoints

The entities named in disclosed activities are the clearest available signal for where the firm is directing attention.

01HOUSE OF REPRESENTATIVES

13 mentions

02SENATE

13 mentions

Industry Profile

AI-classified industry allocation based on the firm's filing activity.

Confidence

83%

Industry count

Biopharma

100%

Registrant industry was derived from the weighted mix of labeled clients across filings, spend, and activity volume.

Recent Filings

The latest disclosures filed by this firm.

STUDENTS FOR LIFE OF AMERICAQ1

2026 first quarter0 issues0 lobbyists

May 18, 2026

NANODXQ1

2026 first quarter3 issues3 lobbyists

Medicare/MedicaidDefense

ACUITY STRATEGIC PARTNERS LLC

Reported Income Over Time

Client Portfolio

What They Lobby On

Defense

Medicare/Medicaid

Government Touchpoints

Industry Profile

Recent Filings

Lobbyists Employed

Budget/Appropriations

Food Industry (safety, labeling, etc.)

Health Issues